Record overview
Status and phase
Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2, PHASE3
Sponsor: RemeGen Co., Ltd.
Condition: Gastric Cancer
NCT05980481
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: primary_completion_date_past_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.